FDA Approved: XTAMPZA ER — Supplemental Application (Collegium Pharmaceutical, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for XTAMPZA ER (oxycodone) submitted by Collegium Pharmaceutical, Inc., updating the product's labeling or indicatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noncancer Pain

Drugs mentioned

• XTAMPZA ER (Oxycodone)

Snippet

SUPPL AP for XTAMPZA ER (OXYCODONE)